213 filings
Page 9 of 11
UPLOAD
8nw5nyeb05tf
15 Aug 18
Letter from SEC
12:00am
S-3
wbv3593w
9 Aug 18
Shelf registration
5:27pm
8-K
ohwlnuc1rzw8dk
9 Aug 18
Kala Pharmaceuticals Reports Second Quarter 2018 Financial Results
7:10am
8-K
fwt cogmf5r6
14 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
b055v kwkye
10 May 18
Kala Pharmaceuticals Reports First Quarter 2018 Financial Results
7:05am
DEFA14A
gqxl7 6a5tez90
26 Apr 18
Additional proxy soliciting materials
4:07pm
DEF 14A
t6uydiol95nhyn46049v
25 Apr 18
Definitive proxy
4:01pm
CT ORDER
t5x9 ctbajm3xv0
19 Apr 18
Confidential treatment order
12:00am
10-K
9b3gl3ofh24uyl
2 Apr 18
Annual report
12:00am
S-8
aak g481uhbhs
2 Apr 18
Registration of securities for employees
12:00am
8-K
l89uqns2
26 Mar 18
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
6pog33g
12 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
p21ih0n ysk5y
5 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
26jyr70t2
8 Jan 18
Regulation FD Disclosure
12:00am
8-K
rb277uu86j8opf95
5 Jan 18
Kala Pharmaceuticals Announces Topline Results for Two Phase 3 Trials (STRIDE 1 and STRIDE 2) of KPI-121 0.25% in Dry Eye Disease
12:00am
UPLOAD
ghy x2mise
28 Nov 17
Letter from SEC
12:00am
8-K
rqw5si2tvnzmw qn
13 Nov 17
Departure of Directors or Certain Officers
12:00am